SID launches project on The Burden of Skin Disease Co-Morbidities 
with Washington, DC conference

Late last year SID launched its new project on The Burden of Skin Disease Co-Morbidities.  The project is a follow-up to the Burden of Skin Disease Report released in 2005. 

Project Overview
Building on its 2004 study of the Burden of Skin Disease, the Society for Investigative Dermatology (SID) has launched a new initiative to determine the Burden of Skin Disease Co-Morbidities. In recent years, there has been increasing evidence linking various skin diseases with a number of co-morbid conditions, some of which occur as a consequence of treatment for severe skin disease.


The multi-year, multi component project is designed to facilitate interaction and collaboration across multiple medical disciplines and fields, in order to
  • identify the depth and state of knowledge on connections between dermatologic and non-dermatologic diseases, including their existence, scientific basis and prevalence;
  • make recommendations pertaining to support of basic and clinical research in the area; and
  • enhance public (including media and policy) awareness and public and policy support for basic and clinical research in the area.
  • Abbott
  • Amgen
  • Centocor, Inc.
  • OSI Pharmaceuticals
For more information on this project click here